LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

This is the German article written by Dr. Fabian Rauscher, Scientific Informatics Manager, Europe, Certara, which was published on LABO titled ‘Data utilisation and data infrastructure in drug development: Data, Data, Data’. ​

​At Certara, specialists are currently working on solutions that can interpret and summarise data formats that were previously unsuitable for data analysis and can make previously inaccessible information usable for research.​

​The platform can use AI and deep learning to suggest entirely new molecules or molecule variants with properties that offer advantages over established substances. Traditional chemical approaches are often limited to known molecular structures. However, AI can suggest new, unconventional molecules and compounds that the researchers might not have considered. This could mean a revolution in drug development in the not-too-distant future.​